December 09, 2024

AI, AR & Social Media Transform Cosmetic Dermatology

Learn how AI and AR technologies are reshaping cosmetic dermatology and the impact of social media platforms on beauty standards.

Conexiant

November 25, 2024

Genetic Insights: T2D, HbA1c and Skin Cancer Risk

New genetic analysis suggests a surprising link between type 2 diabetes, glycated hemoglobin levels, and reduced risk of certain skin cancers, highlighting the potential role of genetic methods in investigating disease associations.

Conexiant

April 30, 2024

Improving Measurement of Postinflammatory Hyperpigmentation With Novel Scale

Researchers have developed a scale to assess postinflammatory hyperpigmentation.

Conexiant

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant

July 31, 2024

Alopecia Areata Linked to Mental, Autoimmune Risks

New study published in JAMA Dermatology reveals that patients newly diagnosed with alopecia areata face a higher risk of developing psychiatric and autoimmune disorders.

Conexiant

August 05, 2024

Global Study Reveals Body Appreciation Trends

A recent study revealed significant cross-cultural differences in body appreciation among women from six countries, with Black Nigerian women reporting the highest levels and White Western women reporting the lowest.

Conexiant

October 11, 2024

Skin Pigmentation: Rethinking Drug Efficacy

With skin pigmentation influencing drug binding and potentially altering therapeutic outcomes, understanding melanin's role in pharmacokinetics is key to advancing equitable treatments.

Conexiant

June 05, 2024

Noncompete Ban May Not Help Nonprofit Workers

Health care professionals welcome the FTC's new rule banning noncompete agreements but are concerned it may not protect those in nonprofit health care settings, potentially impacting most of the nation's medical professionals.

KFF Health News

July 23, 2024

Drug Industry Middlemen Defend Model at Congressional Hearing

They attributed the high costs to "patent abuses" by drug manufacturers, which delay the launch of cheaper generic and biosimilar medicines.

Reuters